USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
RETROTHERAPY, LLC
Address:
4519 GRETNA ST
BETHESDA, MD 20814-3956
Phone:
N/A
URL:
N/A
EIN:
168058459
DUNS:
145949066
Number of Employees:
1
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,118,394.00 3

Award List:

Optimization of a method to reduce expression of progerin, the cause of HGPS (Pro

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$372,089.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This proposal seeks to develop a specific and efficient means to reduce or eliminate the production of the progerin protein, the cause of the premature aging disease Hutchinson-Gilford Progeria Syndrome (HGPS). A de no vo point mutation in codon 608 of the lamin… More

Development of tools to modify globin gene expression in stem cells

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$521,305.00
Agency:
HHS
Principal Investigator:
Lloyd G. Mitchell – 301-503-1202
Abstract:
DESCRIPTION (provided by applicant): Development of tools to modify globin gene expression in stem cells The objective of this proposal is to develop a treatment for patients with sickle cell disease. The development of methods for treating common geneticdiseases, such as sickle cell disease remains… More

Correcting Aberrant Splicing of the Human CD22 Gene

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$225,000.00
Agency:
HHS
Principal Investigator:
Lloyd G. Mitchell – 301-503-1202
Abstract:
DESCRIPTION (provided by applicant): B-precursor acute lymphoblastic leukemia (BPL) is the most common form of cancer in children and adolescents. This project addresses an urgent and unmet need for the treatment of aggressive, treatment refractory BPL. Two recent studies have found a deletion of… More